Clinical trial

A Real-world Study of Inetetamab for First-line Treatment of MBC

NCT05980208

StatusNOT_YET_RECRUITING

Study typeOBSERVATIONAL

Start date2023-09-01

PhaseN/A

Study timeline

Study start (estimated)2023-09-01Date precision: day

Registry last updated2023-08-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Real-world Studyunresolved

Interventions

InetetamabDRUG

Sponsors & collaborators

Hunan Cancer Hospitallead sponsor

Hunan Medical University General Hospitalcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05980208 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.